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Introduction: To compare mean best‑corrected visual acuity (BCVA), retinal sensitivity (RS), and bivariate 
contour ellipse area (BCEA) in patients with adult‑onset foveomacular vitelliform dystrophy (AOFVD) 
and healthy subjects (HSs), reporting also functional disease‑related changes in the different stages of the 
AOFVD disease. Materials and Methods: In this observational cross‑sectional study, a total of 19 patients (30 
eyes; 12 female and 7 male) with AOFVD were enrolled, and 30 patients (30 eyes; 16 female and 14 male) 
were recruited as age‑matched control group (74.36 ± 9.17 years vs. 71.83 ± 6.99 years respectively, P = 0.11). 
All patients underwent a complete ophthalmologic examination, fundus autofluorescence and fluorescein 
angiography, spectral‑domain optical coherence tomography and microperimetry (MP)‑1 analysis. The data 
collection included mean BCVA, mean RS measured by means of MP‑1, BCEA, and central retinal thickness. 
Results: All the functional parameters (BCVA, RS, and BCEA) were significantly worse in AOFVD group 
than HS. Subgroup analysis showed that the most significant functional changes, quantified by mean BCVA, 
RS, and BCEA, were in the atrophic stage (P = 0.03, P = 0.01, and P = 0.001, respectively). All the functional 
parameters were well correlated in the different stages. Conclusions: This study further confirms the good 
visual prognosis in the AOFVD eyes. Fixation stability measurement using BCEA demonstrates good 
evaluation of visual performance integrating traditional functional parameters. It may also serve for further 
rehabilitative purposes in atrophic eyes.
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Adult‑onset foveomacular vitelliform dystrophy (AOFVD), 
first described by Gass[1] in 1974, is characterized by a 
yellow, solitary, round or oval subretinal macular lesion 
that resembles juvenile‑onset vitelliform macular dystrophy 
and Best’s disease. Further studies showed that AOFVD was 
a heterogeneous group of disorders displaying variability 
in the size shape, pigmentary changes, and distribution 
of the lesions (lesion often centered by a pigmented spot) 
and a number of different terms and abbreviations for this 
disease.[2,3]
Cl inicopathological  s tudies  showed a  massive 
accumulation of lipofuscin pigments within the macular 
retinal pigment epithelium (RPE) and loss of the RPE 
and photoreceptor cell layer with infiltration of pigment 
containing macrophages in the central area.[4‑7] Recently, 
spectral‑domain optical coherence tomography (SD‑OCT) 
studies confirmed the hypothesis that the location of the 
yellowish material is under the sensory retina and above 
the RPE.[8‑10]
Fundus‑related perimetry, also known as microperimetry 
(MP), has been used to evaluate macular sensitivity and retinal 
fixation in patients with various macular diseases.[11‑13] The 
most commonly used fundus perimeter device is the MP‑1 
microperimeter (Nidek Technologies, Japan). The widely 
accepted description of the stability and location of fixation is 
based on Fujii et al.’s original classification.[14] Various studies 
have demonstrated that a bivariate contour ellipse area (BCEA) 
can describe the locus of fixation in normal and affected 
individuals.[15‑20] The area of this ellipse gives an indication of 
fixation stability, with larger areas corresponding to poorer 
fixation stability. This method is considered superior than 
conventional three‑step Fujii’s classification in quantifying 
fixation.[21]
The purpose of this study was to compare mean best‑corrected 
visual acuity (BCVA), retinal sensitivity (RS), and BCEA in 
patients with AOFVD and healthy subjects (HSs), to analyze 
patients with AOFVD to evaluate functional disease‑related 
changes, also in relation to the different stages of AOFVD 
disease; and finally to correlate mean BCEA with mean RS and 
mean BCEA in the different stages.
Materials and Methods
In this observational cross‑sectional study, 30 eyes of 
19 patients (12 females and 7 males) with AOFVD were 
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enrolled. Thirty eyes of 30 patients (14 males and 16 females) 
volunteer HS were enrolled as control group.
All participants gave written informed consent before 
enrollment. Institutional Board Approval was obtained 
from Ethics Committee of our institution, and the research 
conformed to the Declaration of Helsinki.
Inclusion criteria were patients in all stages of AOFVD 
disease diagnosed by means of fundus autofluorescence (FAF), 
fluorescein angiography (FA), and SD‑OCT; age ≥50 years; 
normal or subnormal electrooculogram findings; normal 
electroretinogram findings and color vision. We excluded 
patients who had a history of vitreoretinal disease; history of 
intravitreal corticosteroid injection, anti‑vascular endothelial 
growth factor injection and photodynamic therapy; refractive 
errors more than ±6 diopters (D); amblyopia; history of 
intraocular surgery within 6 months. Exclusion criteria were 
the same for both groups.
All patients underwent a complete ophthalmologic 
examination, including BCVA using the Snellen chart, 
biomicroscopy of the anterior segment, Goldmann applanation 
tonometry, dilated fundus examination with indirect 
ophthalmoscopy and SD‑OCT scans (Spectralis OCT, 
Heidelberg, Germany), in a pattern of 20° × 15° raster scans, 
consisting of 19 high‑resolution line scans using a volumetric 
software protocol. Central retinal thickness (CRT) was 
measured using standard protocols of the Heidelberg software.
FA and FAF (Spectralis, Heidelberg, Germany) were 
performed in all patients, to exclude the presence of choroidal 
neovascularization.
MP‑1 analysis (MP‑1, Nidek Technologies, Japan) was 
performed in all patients using a red cross of 2° such 
as a fixation target, white background illumination of 4 
asb (1.27 cd/m2), Goldmann III stimuli, with a projection time 
of 200 ms, customized grid of 45 stimuli around 10°, centered 
on the fovea. We used a 4‑2 staircase strategy and the initial 
projecting sensitivity was fixed at 8 dB. Patients underwent 
brief training at the beginning of each MP. The stability of 
fixation was quantified by calculating a BCEA encompassing 
68% of fixation points (±1 standard deviation [SD]), using the 
formula previously developed by Timberlake et al.[16]
Patients with AOFVD were divided into four groups 
depending on the clinical stage of the disease, as proposed for 
typical Best disease (1) vitelliform stage; (2) pseudohypopyon 
stage; (3) vitelliruptive stage; and (4) atrophic stage; based 
on the overall appearance of the yellowish material. We also 
divided patients into two groups on the basis of the absence/
presence of hyporeflective spaces previously assimilated to 
subretinal fluid.[9]
The data collection included mean BCVA, mean RS 
measured by means of MP‑1, BCEA, and CRT [Fig. 1].
Statistical analysis
All quantitative data were expressed as mean ± SD. The 
normality of distributions was verified by Shapiro–Wilk 
normality test. BCEA (deg2) was normalized by logarithmic 
transformation (Shapiro–Wilk test, P < 0.05). The BCVA was 
analyzed using the individual logarithm of the minimum angle 
of resolution (logMAR) acuity data points, converting from 
decimal unit. To compare HSs and AOFVD group a one‑tailed 
unpaired t‑test was performed. All patients were then stratified 
by stage of the disease to analyze differences between groups 
using a univariate analysis of variance with Tukey's post‑hoc 
test. Pearson’s correlation test was performed for comparisons. 
P <0.05 was considered statistically significant, and P < 0.001 was 
considered to be highly statistically significant. All calculations 
were carried out using the SPSS software (version 19; SPSS Inc., 
Chicago, IL, USA).
Results
A total of 19 patients (30 eyes; 12 female and 7 male) with 
AOFVD were enrolled, and 30 patients (30 eyes; 16 female 
and 14 male) were recruited as an age‑matched control 
group (74.36 ± 9.17 years vs. 71.83 ± 6.99 years respectively, 
P = 0.11). Eleven patients (57.89%) had bilateral disease.
Mean BCVA (−0.41 ± 0.35 vs. 0.01 ± 0.02 logMAR, P < 0.001) 
and RS (13.43 ± 3.23 dB vs. 17.12 ± 1.86 dB, P < 0.001) in AOFVD 
group were overall reduced respect to control group. Moreover, 
mean logarithmic BCEA (logBCEA) was significantly higher 
in AOFVD group than HSs (0.07 ± 0.40 deg2 vs. −0.29 ± 0.38 
deg2, P < 0.001).
We conducted a subgroup analysis of AOFVD patients 
according to the stage of the disease. The main characteristics 
of the subgroups are summarized in Table 1.
Post hoc analysis showed a significant reduction of 
logBCEA between vitelliform and atrophic subgroups (mean 
difference: 0.52 ± 0.12 deg2, P = 0.03). Moreover, we found a 
significant reduction in RS between pseudohypopyon and 
atrophic subgroups (mean difference: 4.50 ± 1.71 dB, P = 0.03) 
and between vitelliruptive and atrophic subgroups (mean 
difference: 5.58 ± 1.85 dB, P = 0.01) [Fig. 2].
The subgroups analysis regarding subretinal fluid 
demonstrated that the mean logBCEA did not change 
significantly between groups (−0.07 deg2, 95% confidence 
interval [CI]: −0.38–0.25, P = 0.62). Instead mean RS significantly 
increased in the group without intraretinal fluid (2.68 dB, 95% 
CI: 0.26–5.09, P = 0.03) [Fig. 3].
Figure 1: Fundus photograph showing typical well-circumscribed 
yellow lesion (a), superimposition with microperimetric interpolated 
map (b) and spectral-domain optical coherence tomography scan 
showing highly reflective material between outer nuclear layer and 
retinal pigment epithelium (c)
c
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The relationship between BCVA and BCEA was significant 
for each stage of the disease; increasing in logMAR visual acuity 
lead to BCEA enlargement in vitelliform (r = 0.36, P = 0.001), 
pseudohypopyon (r = 0.28, P = 0.002), vitelliruptive (r = 0.32, 
P = 0.001), and atrophic stages (r = 0.41, P < 0.001). Similar 
relationship was found between RS and BCVA in vitelliform 
(r = −0.43, P = 0.001), pseudohypopyon (r = −0.19, P = 0.03), and 
atrophic stages (r = −0.30, P < 0.001) but not in vitelliruptive 
stage (r = −0.05, P = 0.06).
Discussion
In this observational study, we analyzed the functional disease 
related‑changes in patients with AOFVD. We evaluated BCVA, 
RS, and fixation stability using BCEA analysis at different stages 
Table 1: Main characteristics of the adult-onset foveomacular vitelliform dystrophy subgroups and controls
Variables Stage of the disease Controls (n=30) P
Vitelliform (n=13) Pseudohypopyon (n=7) Vitelliruptive (n=5) Atrophic (n=5)
Age (years) 78.37 74.5 66 70.66 74.36 0.09*
SD 5.77 10.99 7.16 14.04 9.17
Female, n (%) 8 (100) 3 (42.85) 2 (40) 2 (66.66) 16 (53.33) 0.04†
CRT (µm) 328.92 315.42 275.4 172.8 290.83 0.002*
SD 115.40 64.76 77.07 66.41 105.10
BCVA 0.31 0.41 0.32 0.72 0.01 <0.001*
SD 0.11 0.12 0.17 0.58 0.02
logBCEA (deg2) −0.04 0.10 −0.07 0.48 −0.30 0.001*
SD 0.37 0.26 0.57 0.17 0.38
Sensitivity (dB) 13.14 14.34 15.42 9.84 17.12 <0.001*
SD 2.23 3.23 4.36 2.03 1.86
P: *Analysis of variance, †χ2 value. n: Number of eyes, SD: Standard deviation, CRT: Central retinal thickness, BCVA: Best-corrected visual acuity (logMAR), 
logBCEA: Logarithmic bivariate contour ellipse area, logMAR: Logarithm of the minimum angle of resolution
Figure 3: (a) Mean logarithmic bivariate contour ellipse area (deg2) and (b) retinal sensitivity (dB) in adult-onset foveomacular vitelliform dystrophy 
patients with or without subretinal fluid
ba
Figure 2: (a) Mean logarithmic bivariate contour ellipse area (deg2) and (b) retinal sensitivity (dB) in adult-onset foveomacular vitelliform 
dystrophy
ba
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of disease to investigate the effect of morphological features 
on retinal function.
Not surprisingly, in the AOFVD group, all the functional 
parameters are significantly reduced when compared to the 
HSs. The most significant functional decay occurs in the 
atrophic stage, confirming findings previously reported.[22‑24] 
Variable degrees of visual dysfunction were described, but 
usually, AOFVD patients have a good preservation of visual 
acuity.[3]
In this study, we first reported the analysis of fixation stability 
using BCEA in the AOFVD eyes. It demonstrated a good 
relationship with BCVA at each stage of the disease, confirming 
its ability to reflect visual function and disease‑related 
functional changes. Similar results were obtained with RS that 
negatively correlated with BCVA, but not in vitelliruptive stage. 
The negative correlation is easily explained with the use of 
logMAR acuity to quantify BCVA. However, we can speculate 
that RS and BCEA are both useful methods to analyze visual 
function among different AOFVD stages.
BCEA is a methodology used to quantify fixation stability, 
based on the SD of the horizontal and vertical eye movements, 
which is represented by a bivariate normal ellipse that 
enclosed fixation points. Using logBCEA, an interval variable 
has several advantages: it contains more information than 
the three‑step grading scale, its variability is independent 
of the magnitude, and its quantitative expression is useful 
for statistical analyses in clinical trials.[16,21] Moreover, the 
Fujii’s classification has significant limitations: it does not 
make allowances for the typical elliptical nature of fixation 
distributions[25] or for the multimodal fixation patterns 
frequently exhibited by people with macular disease.[26‑29] It 
cannot differentiate between a subject who has good fixation 
within two discrete, yet spatially distant, retinal loci and one 
who has genuinely poor fixation, and is very poorly related 
to any parameter of reading.
The natural course of the AOFVD lesion includes vitelliform 
collapse and outer retinal atrophy. The progression in the 
atrophic stage usually takes years to develop.[2,3,22] It is also 
well known that patients with progressive central scotoma 
use self‑adaptive strategies to use peripheral retina in place of 
damage fovea.[26] Low vision rehabilitation is effective in such 
cases, especially to maintain and optimize reading ability.[30‑32] 
In our opinion, BCEA collection has a dual implication; it not 
only can integrate visual function evaluation but also can 
identify patients who need visual rehabilitation to improve 
visual performance as well as the quality of life.
The accumulation of subretinal fluid and increase in 
choroidal thickness are related to inflammatory or damaged 
RPE attempts to remove waste products, water and acid 
product of metabolism.[33,34] In our series, the presence 
of subretinal fluid did not influence visual function, but 
conversely, visual function was more affected in eyes without 
fluid. Vitelliform and atrophic are both “without fluid” stages, 
thus this finding may further corroborate the visual function 
decline in atrophic eyes.
The main limitation of the present study is the small sample 
size, even if AOFVD is not a frequent disease. Moreover, 
we took into account morphological stages solely but not 
microstructural alterations.
Conclusions
Our findings further confirm that AOFVD patients have a good 
functional prognosis, because fixation stability, RS and visual 
acuity remain relatively unaffected until the late stage of the 
disease. Moreover, fixation stability measurement using BCEA 
allows a good quantification of visual performance, detecting 
functional decline among AOFVD stages. Its use may integrate 
traditional parameters, ensuring an evaluation of possible 
candidates to any visual rehabilitation strategies.
Further studies will need to determine the effectiveness of 
visual rehabilitation strategies in the AOFVD eyes, to confirm 
the importance to add BCEA in visual assessment.
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